2025
2024
Domengé O, et al. - Trends in prevalence of major etiologies leading to heart failure in young patients: An integrative review. Trends Cardiovasc Med. 2024 Feb;34(2):80-88. doi: 10.1016/j.tcm.2022.09.005. Epub 2022 Sep 22. PMID: 36155830.
2023
2022
Jouve C, et al - Cardiomyocytes derived from human-induced pluripotent stem cell culture in rod-shaped micropattern. Arch Cardiovasc Supp. 2022 Jun; 14 (2):180-181 . doi : 10.1016/j.acvdsp.2022.04.057
Delacroix C, et al - Rôle des intégrines dans la fibrose cardiaque. Med Sci (Paris), 2022 May; 38 : 438-444. doi : 10.1051/medsci/2022055
2021
Ladouceur M, et al. Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle. Heart. 2021 Sep;107(17):1384-1389. doi: 10.1136/heartjnl-2020-318787. Epub 2021 May 6. PMID: 33958396.
Waldmann V, et al - Catheter ablation in adults with congenital heart disease: A 15-year perspective from a tertiary centre. Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):455-464. doi: 10.1016/j.acvd.2020.12.005. Epub 2021 Apr 10. PMID: 33846095.
Baron É, et al. - Management and outcomes of hypertrophic cardiomyopathy in young adults. Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):465-473. doi: 10.1016/j.acvd.2020.12.006. Epub 2021 Mar 17. PMID: 33744178.
Fayol A, et al. - French COVID cohort study group. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021 Jun;8(3):2232-2239. doi: 10.1002/ehf2.13315. Epub 2021 Mar 27. PMID: 33773099; PMCID: PMC8120370.
Azizi M, et al. - Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021 Jun 26;397(10293):2476-2486. doi: 10.1016/S0140-6736(21)00788-1. Epub 2021 May 16. PMID: 34010611.
Seguret M, et al. - Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies. Biomedicines. 2021 May 18;9(5):563. doi: 10.3390/biomedicines9050563. PMID: 34069816; PMCID: PMC8157277.
Jouve C, et al - Improvement in mitochondrial oxidative phosphorylation of cardiomyocytes derived from human-induced pluripotent stem cells using micropatterned anisotropic substrates. Arch Cardiovasc Dis. 2021 May; 13 (2), 207-208. doi: 10.1016/j.acvdsp.2021.04.146
Garnier S, et al - Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur Heart J. 2021 May 21;42(20):2000-2011. doi: 10.1093/eurheartj/ehab030. Erratum in: Eur Heart J. 2021 May 21;42(20):2011. doi: 10.1093/eurheartj/ehab192. PMID: 33677556; PMCID: PMC8139853.
Santos-Zas I, et al. - Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021 Mar 5;12(1):1483. doi: 10.1038/s41467-021-21737-9. PMID: 33674611; PMCID: PMC7935973.
Hulot JS, et al. - HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes. - J Am Coll Cardiol. 2021 Feb 2;77(4):420-422. doi: 10.1016/j.jacc.2020.11.051. PMID: 33509398.
Melhem NJ, et al. - Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function After Myocardial Infarction Through Kynurenine. Circulation. 2021 Feb 9;143(6):566-580. doi: 10.1161/CIRCULATIONAHA.120.050301. Epub 2020 Dec 4. PMID: 33272024.